Fig. 2
From: Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells
CD133+ HPCs enhances breast cancer cell proliferation and reduces their apoptosis in vitro. Data show representative flow cytometry charts, or present the mean ± SD of each group from three separate experiments. a The proliferation of cells; b The images of apoptotic cells; c Quantitative analysis of apoptotic cells. *P < 0.05, compared with CD133- HUCBCs group